JANSSEN-CILAG A/S: Financial statements 2017
CVR: 19248615
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
JANSSEN-CILAG A/S (CVR 19248615) has filed annual accounts for 2017. In 2017, the company reported revenue of DKK 968,109,000 and a net result of DKK 37,063,000 compared with DKK 59,607,000 the year before. That is an increase of 16% compared with the year before. The profit margin was 3.8%. Equity in the 2017 report amounted to DKK 314,947,000. The solvency ratio was 53.3%. The company had 116 employees in the financial year.
- Revenue
- DKK 968,109,000
- Gross Profit
- DKK 236,122,000
- Profit/Loss
- DKK 37,063,000
- Equity
- DKK 314,947,000
- Total Assets
- DKK 590,967,000
- Employees
- 116
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | 968.1 mio. | 236.1 mio. | 37.1 mio. | 314.9 mio. | 116 |
| 2016 | 834.7 mio. | 261.5 mio. | 59.6 mio. | 277.9 mio. | 107 |
| 2015 | 874.3 mio. | 251.7 mio. | 10.5 mio. | 218.3 mio. | 49 |
| 2014 | 875 mio. | 273 mio. | 27.7 mio. | 203.6 mio. | 52 |
| 2013 | 386.4 mio. | 107.8 mio. | 14.2 mio. | 80.9 mio. | 44 |
Official annual report
Keep an eye on JANSSEN-CILAG A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
JANSSEN-CILAG A/S has published its annual report for 2016. Revenue came to DKK 834,738,000, and the net result was DKK 59,607,000.
About JANSSEN-CILAG A/S
JANSSEN-CILAG A/S is a Danish company of the type Aktieselskab based in København Ø, founded in 1969. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named JANSSENPHARMA A/S. The management consists of Mario Klesse. The board consists of Jesper Bilde Puck Nielsen (chair), Liana Akhmetzhanova, Mario Klesse and Nevret Mahmudovski. The company is owned by Janssen Cilag AB. The company has 117 employees (2026). In 2025, the company reported revenue of DKK 1,442,304,000 and a net result of DKK 43,183,000 compared with DKK 64,466,000 the year before. Equity in the 2025 report amounted to DKK 216,425,000.